GTHP today
Trend
—
Key levels
—
Latest news & SEC filings
SEC FilingGuided Therapeutics Inc filed an insider trading report (Form 4)
All GTHP news →OTC · Healthcare
GUIDED THERAPEUTICS INC (GTHP)
What Is the Price Target for GTHP?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is GTHP a Buy or Sell Right Now?
Thesis
- •Revenue growing 10857.1% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for GTHP.
Start Free Trial →Is GTHP Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
21
Moat Score
NONE
3/9
Piotroski Score
-254.9
Altman Z-Score
What Is Smart Money Doing with GTHP?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Imhoff John E | director 10% owner | Buy | 1,650,215 | $116K | Sep 30, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →GTHP Growth Story
Revenue YoY
10857.1%
3yr Revenue CAGR
289.3%
EPS Growth YoY
20%
FCF Growth YoY
4.4%
Revenue Trend
ACCELERATING
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for GUIDED THERAPEUTICS INC (GTHP) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →GTHP — frequently asked questions
Why is GTHP stock moving today?
Latest GTHP news — Oct 27, 2026: Guided Therapeutics Inc filed an insider trading report (Form 4)
Did GTHP beat earnings?
GTHP last reported on Aug 13, 2026: EPS -$0.01.
Does GTHP pay a dividend?
Yes. GTHP's dividend yield is 2.02%.
What are insiders doing with GTHP?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on GTHP?
Oct 27, 2026: Guided Therapeutics Inc filed an insider trading report (Form 4)